Pages that link to "Q33871884"
Jump to navigation
Jump to search
The following pages link to Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa (Q33871884):
Displaying 50 items.
- Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis (Q21144604) (← links)
- Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings (Q24600270) (← links)
- Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care (Q24610933) (← links)
- Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast (Q24620256) (← links)
- Point of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet? (Q26746020) (← links)
- Host immunity to Cryptococcus neoformans (Q26823438) (← links)
- Preventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral Therapy (Q26994750) (← links)
- Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal (Q27012487) (← links)
- Integrated therapy for HIV and cryptococcosis (Q28077707) (← links)
- HIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited Settings (Q28078958) (← links)
- Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa (Q28534733) (← links)
- A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward? (Q28541690) (← links)
- Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia (Q28748511) (← links)
- Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy (Q30240687) (← links)
- Cryptococcal meningitis: epidemiology and therapeutic options (Q33633343) (← links)
- Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts (Q33792332) (← links)
- Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay (Q33803185) (← links)
- Is HIV-associated tuberculosis a risk factor for the development of cryptococcal disease? (Q33854505) (← links)
- Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in Uganda (Q33855961) (← links)
- Outcomes of cryptococcal meningitis in antiretroviral naïve and experienced patients in South Africa (Q33888707) (← links)
- Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. (Q34020746) (← links)
- Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV-positive outpatients beginning antiretroviral therapy in Mwanza, Tanzania (Q34024241) (← links)
- Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya (Q34193503) (← links)
- High prevalence of tuberculosis and serious bloodstream infections in ambulatory individuals presenting for antiretroviral therapy in Malawi (Q34326041) (← links)
- Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa (Q34477198) (← links)
- Six-month mortality among HIV-infected adults presenting for antiretroviral therapy with unexplained weight loss, chronic fever or chronic diarrhea in Malawi. (Q34489764) (← links)
- Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda (Q34516367) (← links)
- Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions (Q34516548) (← links)
- High prevalence of Cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia (Q34613471) (← links)
- An update on Cryptococcus among HIV-infected patients (Q34625655) (← links)
- Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa (Q34687565) (← links)
- Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam (Q34692926) (← links)
- Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008. (Q35004926) (← links)
- Immune reconstitution inflammatory syndrome in HIV-infected patients (Q35100818) (← links)
- Fungal diagnostics (Q35137799) (← links)
- Implementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemia (Q35170385) (← links)
- Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012. (Q35171867) (← links)
- Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis (Q35353193) (← links)
- Cryptococcosis diagnosis and treatment: What do we know now (Q35395169) (← links)
- Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study (Q35396977) (← links)
- Trends in prevalence of selected opportunistic infections associated with HIV/AIDS in Uganda (Q35534405) (← links)
- Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy (Q35656939) (← links)
- Pitfalls in Serological Diagnosis of Cryptococcus gattii Infections (Q35763934) (← links)
- Management of cryptococcal meningitis in a district hospital in KwaZulu-Natal: a clinical audit (Q35853546) (← links)
- Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality (Q35880502) (← links)
- Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study (Q35907878) (← links)
- Significantly improved analytical sensitivity of lateral flow immunoassays by using thermal contrast (Q35914676) (← links)
- Cryptococcal Meningitis: Diagnosis and Management Update. (Q35951094) (← links)
- Evaluation of the FACSPresto, a New Point of Care Device for the Enumeration of CD4% and Absolute CD4+ T Cell Counts in HIV Infection (Q36070274) (← links)
- Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa (Q36070803) (← links)